Alecensa 150 mg is a groundbreaking targeted therapy designed to treat patients with ALK-positive non-small cell lung cancer (NSCLC). Developed by Roche, this innovative oral medication contains the active ingredient Alectinib, a potent ALK inhibitor that has redefined the treatment landscape for advanced lung cancer patients. Alecensa 150 mg is widely recognized for its superior efficacy, reduced toxicity compared to chemotherapy, and its proven ability to delay disease progression, especially in cases involving brain metastases.
Key Product Details:
- Active Ingredient: Alectinib 150 mg
- Form: Hard Capsule
- Administration: Oral Use
- Packaging: Typically 224 capsules per box (exact quantity may vary)
- Manufacturer: Roche
Benefits of Alecensa 150 mg (Alectinib):
- Selective ALK Inhibitor: Specifically targets and blocks the abnormal ALK protein, which drives cancer growth in ALK-positive NSCLC patients.
- Proven Progression-Free Survival: Clinical studies show that Alecensa significantly extends progression-free survival compared to crizotinib, especially in patients with CNS metastases.
- Brain Metastases Penetration: Unlike other therapies, Alecensa is highly effective in treating and preventing the spread of cancer to the brain.
- Improved Tolerability: Patients experience fewer severe side effects compared to traditional chemotherapy and some older ALK inhibitors.
- First-Line Treatment Approval: Approved globally as a first-line treatment for ALK-positive advanced NSCLC.
Indications:
- ALK-Positive Advanced NSCLC: First-line treatment or for patients who have progressed on or are intolerant to crizotinib.
How Does Alecensa (Alectinib) Work?
Alectinib is an advanced ALK tyrosine kinase inhibitor (TKI). It works by:
- Blocking the ALK protein responsible for the uncontrolled growth of cancer cells.
- Penetrating the blood-brain barrier, making it highly effective against brain metastases.
- Preventing the activation of signaling pathways that fuel cancer cell growth.
Dosage and Administration:
- Recommended Dose: 600 mg (4 x 150 mg capsules) twice daily with food.
- Capsules should be swallowed whole; do not open, crush, or chew.
Safety Information:
- Common Side Effects: Fatigue, constipation, muscle pain, swelling, anemia.
- Serious Risks: Liver toxicity, pulmonary issues, bradycardia, and photosensitivity reactions.
- Monitoring: Liver function tests should be performed regularly.
Storage Conditions:
- Temperature: Store below 30°C.
- Packaging: Keep in the original blister pack to protect from moisture.
Why Choose Alecensa 150 mg (Alectinib)?
Alecensa 150 mg has emerged as a first-choice treatment for ALK-positive NSCLC due to its unmatched efficacy in preventing brain metastases, improving patient outcomes, and reducing adverse effects. It has rapidly become the gold standard globally, offering hope and an extended lifespan to lung cancer patients.
Buy Alecensa 150 mg Online:
Searching for a reliable source to buy Alecensa 150 mg (Alectinib Capsules) online? We guarantee authentic Roche products with secure global delivery. Place your order today and gain access to this revolutionary lung cancer treatment.
Değerlendirmeler
Henüz değerlendirme yapılmadı.